Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

NCT07129629 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary
Drug-Susceptible Pulmonary Tuberculosis

Interventions

DRUG: Bedaquiline (B)
DRUG: Moxifloxacin
DRUG: Pyrazinamide (PZA)
DRUG: Delamanid (D)
DRUG: Isoniazid (H)
DRUG: Rifampicin (R)
DRUG: Ethambutol (E)

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Collaborators

[object Object]
[object Object]